Search Results - Mark Selby

Refine Results
  1. 1
    Interaction between hepatitis C virus core protein and E1 envelope protein

    Interaction between hepatitis C virus core protein and E1 envelope protein by Shih‐Yen Lo, Mark Selby, J H Ou

    Published 1996
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Mouse nerve growth factor gene: structure and expression.

    Mouse nerve growth factor gene: structure and expression. by Mark Selby, Robert H. Edwards, F. Sharp, William J. Rutter

    Published 1987
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat.

    Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat. by Mark Selby, Eric S. Bain, Paul A. Luciw, B. Matija Peterlin

    Published 1989
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Processing of the native nerve growth factor precursor to form biologically active nerve growth factor.

    Processing of the native nerve growth factor precursor to form biologically active nerve growth factor. by Robert H. Edwards, Mark Selby, Pablo D. García, William J. Rutter

    Published 1988
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells.

    Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. by Barbara Doe, Mark Selby, Susan Barnett, J Baenziger, Christopher M. Walker

    Published 1996
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Analysis of a major human chorionic somatomammotropin gene. Evidence for two functional promoter elements.

    Analysis of a major human chorionic somatomammotropin gene. Evidence for two functional promoter elements. by Mark Selby, Andrea Barta, John D. Baxter, G I Bell, Norman L. Eberhardt

    Published 1984
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis

    FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis by Rony Dahan, Emanuela Sega, John Engelhardt, Mark Selby, Alan J. Korman, Jeffrey V. Ravetch

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis

    FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis by Rony Dahan, Emanuela Sega, John F. Engelhardt, Mark Selby, Alan J. Korman, Jeffrey V. Ravetch

    Published 2015
    Get full text Get full text
    Errata/Corrigenda
    Save to List
    Saved in:
  9. 9
    Activation of the <i>grp78</i> and <i>grp94</i> Promoters by Hepatitis C Virus E2 Envelope Protein

    Activation of the <i>grp78</i> and <i>grp94</i> Promoters by Hepatitis C Virus E2 Envelope Protein by Eva Liberman, Y L Fong, Mark Selby, Qui‐Lim Choo, Lawrence S. Cousens, Michael Houghton, T. S. Benedict Yen

    Published 1999
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Processing and secretion of nerve growth factor: expression in mammalian cells with a vaccinia virus vector.

    Processing and secretion of nerve growth factor: expression in mammalian cells with a vaccinia virus vector. by Robert H. Edwards, Mark Selby, William C. Mobley, Scott L. Weinrich, Dennis E. Hruby, William J. Rutter

    Published 1988
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Increased Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 <i>gag</i> Gene

    Increased Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 <i>gag</i> Gene by Jan zur Megede, Minchao Chen, Barbara Doe, Mary Schaefer, Catherine E. Greer, Mark Selby, Gillis R. Otten, Susan W. Barnett

    Published 2000
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine

    Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine by Noelle K. Polakos, Debbie Drane, John C. Cox, Kin Cheung Ng, Mark Selby, David Chien, Derek T. O’Hagan, Michael Houghton, Xavier Paliard

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses

    Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses by Robert Ralston, Kent Thudium, Karin Berger, C. Kuo, Barbara Gervase, J. Eric Hall, Mark Selby, George Kuo, Michael Houghton, Qui-Lim Choo

    Published 1993
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome

    Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome by Mark Selby, Q L Choo, Karin Berger, George Kuo, Evan S. Glazer, Michael R. Eckart, Cheng-Chi Lee, David Chien, C. Kuo, Michael Houghton

    Published 1993
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Preclinical Characterization of Relatlimab, a Human LAG-3–Blocking Antibody, Alone or in Combination with Nivolumab

    Preclinical Characterization of Relatlimab, a Human LAG-3–Blocking Antibody, Alone or in Combination with Nivolumab by Kent Thudium, Mark Selby, Julie A. Zorn, Gregory D. Rak, Xi-Tao Wang, Roderick T. Bunch, Jason M. Hogan, Pavel Strop, Alan J. Korman

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Cutting Edge: Accelerated Autoimmune Diabetes in the Absence of LAG-3

    Cutting Edge: Accelerated Autoimmune Diabetes in the Absence of LAG-3 by Maria Bettini, Andrea L. Szymczak-Workman, Karen Forbes, Ashley Castellaw, Mark Selby, Xiaoyu Pan, Charles G. Drake, Alan J. Korman, Dario A.A. Vignali

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Hepatitis C virus core and E2 protein expression in transgenic mice

    Hepatitis C virus core and E2 protein expression in transgenic mice by C Pasquinelli, J M Shoenberger, J. Chung, Kyong–Mi Chang, Luca G. Guidotti, Mark Selby, Karin Berger, Richard R. Lesniewski, Michael Houghton, Francis V. Chisari

    Published 1997
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In Vivo

    Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In Vivo by Georg Widera, Melissa A. Austin, Dietmar Rabussay, Cheryl Goldbeck, Susan W. Barnett, Minchao Chen, Louisa Leung, Gillis R. Otten, Kent Thudium, Mark Selby, Jeffrey B. Ulmer

    Published 2000
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Transfection of a differentiated human hepatoma cell line (Huh7) with in vitro-transcribed hepatitis C virus (HCV) RNA and establishment of a long-term culture persistently infected with HCV

    Transfection of a differentiated human hepatoma cell line (Huh7) with in vitro-transcribed hepatitis C virus (HCV) RNA and establishment of a long-term culture persistently infecte... by Byoung J. Yoo, Mark Selby, Joonho Choe, Beom-Seok Suh, Sung‐Hyuk Choi, Joon-Sung Joh, Gerard J. Nuovo, H S Lee, Michael Houghton, Jang H. Han

    Published 1995
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice

    Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice by Marc Dupuis, Kimberly Denis-Mize, Carolyn Woo, Cheryl Goldbeck, Mark Selby, Minchao Chen, Gillis R. Otten, Jeffrey B. Ulmer, John Donnelly, Gary Ott, Donald M. McDonald

    Published 2000
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: